BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 182190)

  • 21. Interaction of plasma membranes with influenza virus. VII. Effect on 3',5'-cyclic adenosine monophosphate phosphodiesterase activity.
    Krizanová O; Lacinová D; Knopp J
    Acta Virol; 1977 Mar; 21(2):97-103. PubMed ID: 17292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat pineal adenosine cyclic 3',5'-monophosphate phosphodiesterase activity: modulation in vivo by a beta adrenergic receptor.
    Oleshansky MA; Neff NH
    Mol Pharmacol; 1975 Sep; 11(5):552-7. PubMed ID: 170502
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
    Menahan LA; Kemp RG
    J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile hormone regulation of CYCLIC AMP and cAMP phosphodiesterase activity in Oncopeltus fasciatus.
    Everson RD; Feir D
    J Insect Physiol; 1976; 22(6):781-4. PubMed ID: 181493
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes of cyclic-AMP and cycic-AMP phosphodiesterase in the progression and regression of experimental atherosclerosis.
    Numano F; Maezawa H
    Ann N Y Acad Sci; 1976; 275():311-20. PubMed ID: 188369
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
    Taylor JE; Shirachi DY
    Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
    [No Abstract]   [Full Text] [Related]  

  • 27. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin-sensitive adenosine 3',5'-cyclic monophosphate phosphodiesterase of hepatocyte plasma membrane.
    Tria E; Scapin S; Cocco C; Luly P
    Biochim Biophys Acta; 1977 Jan; 496(1):77-87. PubMed ID: 189834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity.
    Minneman KP; Iversen LL
    Nature; 1976 Mar; 260(5546):59-61. PubMed ID: 177878
    [No Abstract]   [Full Text] [Related]  

  • 30. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP, adenylate cyclase and cyclic AMP-phosphodiesterase activities in diabetic rat adipocytes.
    Chiappe de Cingolani GE
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):39-46. PubMed ID: 3020875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of levamisole on phosphodiesterase activity.
    Constantopoulos A; Kafasi V; Doulas N; Liakakos D; Matsaniotis N
    Experientia; 1977 Mar; 33(3):395-6. PubMed ID: 192573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal cyclic-AMP phosphodiesterase activity in two strains of dystrophic rat.
    Dewar AJ; Barron G; Richmond J
    Exp Eye Res; 1975 Sep; 21(3):299-306. PubMed ID: 171164
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.
    Kang ES
    Pediatr Res; 1978 Jul; 12(7):761-6. PubMed ID: 211480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interaction between cyclic adenosine-3':5'-monophosphate phosphodiesterase and structural analogs of the substrate].
    Kochetkova MN; Guliaev NN; Tunitskaia VL; Severin ES
    Biokhimiia; 1981 Feb; 46(2):353-60. PubMed ID: 6264977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation of serum-induced changes in cyclic nucleotide levels in cultured fibroblasts by cyclic nucleotide phosphodiesterase.
    Pledger WJ; Thompson WJ; Strada SJ
    Nature; 1975 Aug; 256(5520):729-31. PubMed ID: 168501
    [No Abstract]   [Full Text] [Related]  

  • 37. Alteration of phosphodiesterase activity after 5-bromodeoxyuridine (BUdR) treatment of Dictyostelium discoideum.
    Scrive M; Guespin-Michel JF; Felenbok B
    Exp Cell Res; 1977 Aug; 108(1):107-10. PubMed ID: 196866
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for differences in protein kinase modulator and and phosphodiesterase activator.
    Miyamoto E; Hideshima Y; Teshima Y; Yamazaki R; Kakiuchi S
    J Cyclic Nucleotide Res; 1977 Apr; 3(2):85-94. PubMed ID: 195987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
    Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
    Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.